Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Angiogen
Profile last edited on: 1/9/19      CAGE:       UEI:

Business Identifier: Therapeutics for vascular cancers
Year Founded
----
First Award
1986
Latest Award
1989
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

107 Lakefront Drive
Hunt Valley, MD 21030
   (301) 667-6880
   N/A
   N/A
Location: Single
Congr. District: 02
County: Baltimore

Public Profile

Currently there is no description available for this company.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$200,000
Phase II Dollars
$0
Total Awarded
$200,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1989 1 NIH $50,000
Project Title: Effects of antiogenesis factors on skin flap survival
1987 1 NIH $50,000
Project Title: Retinopathy treatment; heparin-targeted antiangiogenesis
1986 1 NIH $50,000
Project Title: Angiogenesis & detection of CNS tumors
1986 1 NIH $50,000
Project Title: Copper chelators & antiangiogenesis

Key People / Management

  Allan H Fenselau

Company News

There are no news available.